User: **A 29-year-old pregnant woman (G5P3) at 26 weeks 3 days of gestation presents with a 2-week history of gradually increasing exertional dyspnea. Over the last 5 days, she has developed a nonproductive cough, nasal congestion, and subjective fevers. Most concerningly, she experienced chest tightness, palpitations, and presyncope after carrying laundry up a flight of stairs.
Her medical history is significant for Undifferentiated Connective Tissue Disease (UCTD) diagnosed 10 months prior, characterized by biopsy-proven leukocytoclastic vasculitis and intermittent cytopenias (ANA+, anti-Ro+, anti-La+, low complements). Notably, at 10 weeks of gestation, she had a syncopal episode due to severe anemia (Hb 6.2) and thrombocytopenia (Plt 40k) triggered by Parvovirus B19 infection. She is currently on Prednisone (30mg daily), Hydroxychloroquine, and Aspirin.**
ERROR from Resident: HTTP 400: {"error":{"message":"google/gemini-3.0-flash is not a valid model ID","code":400},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}
ERROR from Attending: HTTP 404: {"error":{"message":"No endpoints found for x-ai/grok-2-1212.","code":404},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}
Hello, Expert Clinician here.
In synthesizing the clinical information provided, the most likely unifying diagnosis for this pregnant woman is a flare of her Undifferentiated Connective Tissue Disease (UCTD) with possible cardiac involvement, such as pericarditis or myocarditis, potentially exacerbated by her pregnancy. The key pivot in this case is her history of UCTD with positive anti-Ro and anti-La antibodies, which are associated with connective tissue diseases that can affect the heart, especially in the context of pregnancy.
Top Differentials:
Peripartum Cardiomyopathy: This condition can present with dyspnea, palpitations, and presyncope in pregnant women, typically in the last month of pregnancy or within five months postpartum. However, it is less likely at 26 weeks of gestation and given her specific autoimmune background.
Myocarditis: Given her autoimmune condition and the presence of palpitations and presyncope, myocarditis is a plausible consideration. The presence of anti-Ro and anti-La antibodies can be associated with cardiac involvement in autoimmune diseases.
Pericarditis: This could explain the chest tightness and exertional symptoms, especially in the context of her connective tissue disease. However, the absence of pleuritic chest pain or a pericardial rub makes this less likely.
Pulmonary Embolism: While this is a critical consideration in pregnant women with dyspnea and presyncope, the gradual onset and presence of nasal congestion and cough make it less likely.
Anemia: Given her history of severe anemia, a recurrence could contribute to her symptoms, although it would not fully explain the chest tightness and palpitations.
Why Each Fits or Does Not Fit:
Most Important Next Diagnostic or Management Move:
The most important next step is to obtain an echocardiogram to evaluate cardiac function and look for evidence of myocarditis or pericarditis. This will help assess for any structural or functional cardiac abnormalities that could explain her symptoms.
Teaching Pearl:
In pregnant patients with connective tissue diseases, always consider cardiac involvement as a potential cause of new or worsening symptoms, especially when anti-Ro and anti-La antibodies are present. These antibodies are associated with neonatal lupus and can lead to cardiac complications such as congenital heart block or myocarditis in the mother.
User: **On examination, she is febrile (38°C), tachycardic (122 bpm), tachypnea (22/min), and has an oxygen saturation of 94% on room air.
Key Physical Findings:
Neck: Elevated JVP with a prominent v wave.
Cardiac: Split S2, a holosystolic murmur at the right sternal border, and a left parasternal heave.
Lungs: Scattered crackles without wheezing.
Skin: Reticular hyperpigmentation and trace pitting edema in lower limbs.
Initial Labs:
CBC: WBC 13,700 (predominantly neutrophils), Hb 11.2, Platelets 203,000.
Respiratory Pathogen Panel: Positive for Respiratory Syncytial Virus (RSV).
Chest X-ray: Initially interpreted as "Normal."**
ERROR from Resident: HTTP 400: {"error":{"message":"google/gemini-3.0-flash is not a valid model ID","code":400},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}
ERROR from Attending: HTTP 404: {"error":{"message":"No endpoints found for x-ai/grok-2-1212.","code":404},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}
Expert:
Hello, Expert Clinician here.
The additional clinical findings and laboratory results provide further insight into this patient's condition. The presence of a holosystolic murmur at the right sternal border, elevated JVP with a prominent v wave, and a left parasternal heave suggest significant cardiac involvement, likely related to right-sided heart strain or failure.
Unifying Diagnosis:
The most likely unifying diagnosis is acute right heart failure secondary to pulmonary hypertension, potentially exacerbated by a viral infection (RSV) and underlying connective tissue disease. The elevated JVP with a prominent v wave and the holosystolic murmur suggest tricuspid regurgitation, which can occur with right ventricular overload.
Top Differentials:
Acute Right Heart Failure due to Pulmonary Hypertension: The clinical signs of elevated JVP, parasternal heave, and murmur suggest right heart strain, possibly due to pulmonary hypertension. This could be exacerbated by the RSV infection causing increased pulmonary vascular resistance.
Myocarditis: The tachycardia, fever, and respiratory symptoms could be consistent with myocarditis, especially given her autoimmune background. However, the specific cardiac findings lean more towards right heart involvement.
Pericarditis with Effusion: While pericarditis could explain some symptoms, the specific cardiac findings are more indicative of right heart strain rather than tamponade physiology.
Pulmonary Embolism: The acute presentation with respiratory symptoms and right heart strain could suggest a pulmonary embolism, but the gradual onset and RSV positivity make this less likely.
Exacerbation of UCTD with Cardiac Involvement: Her connective tissue disease could be flaring, leading to cardiac involvement, but the specific findings are more suggestive of pulmonary hypertension.
Key Pivot in the Case:
The key pivot is the combination of right heart strain signs (elevated JVP, holosystolic murmur, parasternal heave) with respiratory symptoms and RSV positivity, suggesting a pulmonary vascular issue exacerbated by infection.
Most Important Next Diagnostic or Management Move:
The most important next step is to perform an echocardiogram to assess for right ventricular function, pulmonary artery pressures, and any structural abnormalities such as tricuspid regurgitation. This will help confirm the presence of pulmonary hypertension and guide further management.
Teaching Pearl:
In patients with connective tissue diseases, viral infections can exacerbate underlying cardiac conditions, such as pulmonary hypertension, leading to acute decompensation. Always consider the impact of infections on the cardiovascular system in these patients.
User: **An Electrocardiogram (ECG) is performed, showing sinus tachycardia with right-axis deviation and T-wave inversions in leads II, III, aVF, and V3 to V5.
A "re-read" of the initial Chest X-ray reveals:
Prominence of the right descending pulmonary artery.
A large left central pulmonary artery with obliteration of the aortopulmonary window.
Diminished retrosternal clear space on the lateral view.
Biomarkers: BNP is elevated at 362 pg/mL (Normal < 100). Troponin is normal.
Imaging:
CTPA: No pulmonary embolism. Confirms tree-in-bud nodularity (RSV) and right ventricular enlargement.
Echocardiogram: Small, hyperdynamic LV (EF 75%). Marked RV dilatation with severely reduced systolic function and septal flattening ("D-shaped" LV). Severe tricuspid regurgitation with an estimated RVSP of 74 mmHg.**
ERROR from Resident: HTTP 400: {"error":{"message":"google/gemini-3.0-flash is not a valid model ID","code":400},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}
ERROR from Attending: HTTP 404: {"error":{"message":"No endpoints found for x-ai/grok-2-1212.","code":404},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}
Expert:
Hello, Expert Clinician here.
The additional diagnostic information solidifies the diagnosis of acute right heart failure due to severe pulmonary hypertension, likely exacerbated by the RSV infection in the context of her underlying connective tissue disease. The echocardiogram findings of marked right ventricular (RV) dilatation, severely reduced RV systolic function, and severe tricuspid regurgitation, along with an elevated right ventricular systolic pressure (RVSP), confirm significant pulmonary hypertension.
Unifying Diagnosis:
The unifying diagnosis is acute decompensated right heart failure due to severe pulmonary arterial hypertension (PAH). This is likely multifactorial, with contributions from her underlying connective tissue disease, RSV infection, and possibly pregnancy-related hemodynamic changes.
Key Findings Supporting the Diagnosis:
Most Important Next Diagnostic or Management Move:
The most important next step is to initiate treatment for pulmonary hypertension and right heart failure. This includes:
Teaching Pearl:
In patients with connective tissue diseases, especially those with positive anti-Ro and anti-La antibodies, there is an increased risk of developing pulmonary arterial hypertension. This can be exacerbated by infections and pregnancy, leading to acute decompensation. Early recognition and management are critical to improving outcomes in these complex cases.
User: **Right Heart Catheterization is performed:
Mean Pulmonary Artery Pressure (mPAP): 57 mmHg (Severe).
Pulmonary Capillary Wedge Pressure (PCWP): 5 mmHg (Normal).
Cardiac Output: 2.7 L/min (Severely low for pregnancy, where 6.0 is expected).
Pulmonary Vascular Resistance (PVR): 19.2 Wood Units (Normal < 2).
Nitric Oxide Challenge: No response (Vasoreactivity negative).
A V/Q scan is performed and is normal, ruling out Chronic Thromboembolic Pulmonary Hypertension (CTEPH).**
ERROR from Resident: HTTP 400: {"error":{"message":"google/gemini-3.0-flash is not a valid model ID","code":400},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}
ERROR from Attending: HTTP 404: {"error":{"message":"No endpoints found for x-ai/grok-2-1212.","code":404},"user_id":"user_2oxytR9Eb14CGa4JZnojbLg5oVg"}
Expert:
Hello, Expert Clinician here.
The right heart catheterization results confirm the diagnosis of severe pulmonary arterial hypertension (PAH). The elevated mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR), along with a normal pulmonary capillary wedge pressure (PCWP), indicate pre-capillary pulmonary hypertension, consistent with PAH rather than left heart disease. The lack of response to the nitric oxide challenge suggests that she is not a candidate for calcium channel blocker therapy, which is only effective in patients with vasoreactive PAH.
Unifying Diagnosis:
The unifying diagnosis is severe pulmonary arterial hypertension secondary to connective tissue disease, exacerbated by pregnancy and RSV infection. This condition is characterized by high pulmonary artery pressures and resistance, leading to right heart failure.
Key Findings Supporting the Diagnosis:
Most Important Next Diagnostic or Management Move:
The most important next step is to initiate targeted therapy for PAH. This includes:
Pulmonary Vasodilators: Start with advanced therapies such as endothelin receptor antagonists (e.g., bosentan), phosphodiesterase-5 inhibitors (e.g., sildenafil), or prostacyclin analogs (e.g., epoprostenol or treprostinil) to lower pulmonary artery pressures and improve cardiac output.
Multidisciplinary Care: Involve a team with expertise in managing PAH in pregnancy, including cardiology, pulmonology, and maternal-fetal medicine specialists.
Consideration of Delivery Timing: Given the severity of her condition, discussions regarding the timing and mode of delivery should be initiated, balancing maternal and fetal risks.
Teaching Pearl:
Pulmonary arterial hypertension in the context of connective tissue diseases, especially with severe manifestations, poses significant risks during pregnancy. Early recognition and aggressive management with targeted PAH therapies are crucial to improving maternal outcomes. Multidisciplinary care is essential in managing these complex cases.
User: **A 29-year-old pregnant woman (G5P3) at 26 weeks 3 days of gestation presents with a 2-week history of gradually increasing exertional dyspnea. Over the last 5 days, she has developed a nonproductive cough, nasal congestion, and subjective fevers. Most concerningly, she experienced chest tightness, palpitations, and presyncope after carrying laundry up a flight of stairs.
Her medical history is significant for Undifferentiated Connective Tissue Disease (UCTD) diagnosed 10 months prior, characterized by biopsy-proven leukocytoclastic vasculitis and intermittent cytopenias (ANA+, anti-Ro+, anti-La+, low complements). Notably, at 10 weeks of gestation, she had a syncopal episode due to severe anemia (Hb 6.2) and thrombocytopenia (Plt 40k) triggered by Parvovirus B19 infection. She is currently on Prednisone (30mg daily), Hydroxychloroquine, and Aspirin.**
Hello, Chief Resident here.
This is a complex presentation of a 29-year-old pregnant patient (G5P3) at 26 weeks gestation with a background of Undifferentiated Connective Tissue Disease (UCTD) and recent Parvovirus B19 infection. The key findings are the subacute progression of exertional dyspnea and cough, culminating in an episode of chest tightness, palpitations, and presyncope—concerning for acute cardiopulmonary decompensation.
Management Note: Given the anti-Ro/La positivity, a fetal echocardiogram is also indicated to screen for congenital heart block, though the maternal presentation is the immediate priority.
Hello Attending Consultant here.
Critique of the proposed plan:
These refinements sharpen diagnostic efficiency and maternal-fetal safety.
Hello, Expert Clinician here.
Pulmonary vascular/cardiac decompensation until proven otherwise — most urgently either pulmonary embolism or pulmonary hypertension/right-heart strain in a pregnant woman with connective tissue disease.
Why this is the best current frame:
- Pregnancy is strongly prothrombotic.
- UCTD/connective tissue disease raises risk for pulmonary arterial hypertension, serositis, myocarditis, and thrombosis.
- The key symptom cluster is not just URI symptoms; it is exertional chest tightness + palpitations + presyncope after stairs, on a background of progressively worsening dyspnea.
- Exertional presyncope is a major red flag for limited cardiac output/right-sided circulatory pathology such as PE, pulmonary hypertension, or cardiomyopathy/myocarditis.
Her nasal congestion/cough/subjective fever may be a concurrent viral illness, but they do not adequately explain the presyncope/chest symptoms.
Why it fits
- Pregnancy is a hypercoagulable state.
- Dyspnea with chest tightness and presyncope is classic concerning physiology.
- Acute worsening with exertion suggests inability to augment pulmonary blood flow.
- Autoimmune disease may further increase thrombotic risk.
Why it may not fully fit
- Symptoms evolved over 2 weeks rather than suddenly, though PE can be subacute or recurrent.
- Nonproductive cough and congestion could point to infection instead, but these are nonspecific.
Why it fits
- CTD can cause pulmonary arterial hypertension, even early in disease.
- Exertional presyncope is especially suggestive.
- Pregnancy can unmask/worsen previously compensated PH because of increased plasma volume and cardiac output.
- Chest tightness, palpitations, and progressive exertional dyspnea are very compatible.
Why it may not fully fit
- We are not told of prior Raynaud, known PH, RV findings, edema, or syncope history.
- URI-like symptoms are less directly explained.
Still, this is a high-stakes diagnosis and may coexist with PE.
Why it fits
- Progressive dyspnea, palpitations, presyncope, and chest tightness.
- CTD can involve myocardium/pericardium.
- Viral prodrome symptoms raise possibility of myocarditis.
- Pregnancy increases hemodynamic stress.
Why it may not fully fit
- 26 weeks is earlier than classic peripartum cardiomyopathy, though not impossible.
- No orthopnea, edema, or clear heart failure symptoms provided.
Why it fits
- She previously had dramatic anemia and thrombocytopenia from parvovirus B19.
- Anemia in pregnancy can cause dyspnea, palpitations, exertional chest discomfort, and presyncope.
- Her autoimmune background also raises risk of hemolysis or cytopenic flare.
Why it may not fully fit
- Anemia alone usually does not explain the particular concern for chest tightness with exertional presyncope as well as PE/PH would.
- Cough/congestion are not directly explained.
This remains very important because severe anemia can either be the main problem or worsen any cardiopulmonary disease.
Why it fits
- Subjective fever, cough, congestion.
- She is on prednisone 30 mg/day, which increases infection risk.
- PJP can present with dyspnea and nonproductive cough.
Why it may not fully fit
- Nasal congestion favors routine viral URI rather than PJP.
- Presyncope/chest tightness with stairs feels more hemodynamically significant than a simple respiratory infection.
Why it fits
- Low complements, cytopenic history, vasculitic disease.
- CTD flare can involve lungs, pleura, pericardium, and blood counts.
Why it may not fully fit
- The stem lacks pleuritic pain, hemoptysis, rash, or obvious inflammatory flare clues.
- Again, the hemodynamic quality of exertional presyncope pushes PE/PH/cardiac disease higher.
The pivot is:
This is not adequately explained by “URI symptoms in pregnancy.” Exertional chest tightness with palpitations and presyncope is a cardiopulmonary warning sign that should trigger urgent evaluation for PE, pulmonary hypertension/right-heart strain, or cardiomyopathy.
That is the clinical hinge. The viral-sounding symptoms are potentially distracting.
Most important first steps:
1. Vitals including pulse ox
2. ECG
3. CBC, CMP, troponin, BNP/NT-proBNP
4. Chest X-ray
5. Urgent transthoracic echocardiogram
- looking for RV dilation/strain, elevated RVSP/PH, LV dysfunction, pericardial effusion
6. Definitive evaluation for PE
- If suspicion remains significant after initial assessment, proceed to pregnancy-appropriate imaging:
- V/Q scan if chest X-ray is normal
- CTPA if chest X-ray abnormal or alternative thoracic diagnosis is needed
If she is hypoxemic, tachycardic, unstable, or strongly suspected of PE, involve obstetrics + maternal-fetal medicine + cardiology/pulmonology early and consider empiric anticoagulation with LMWH while the workup proceeds, depending on bleeding risk and platelet count.
In pregnancy, exertional presyncope is a red-flag symptom.
When dyspnea is accompanied by chest symptoms, palpitations, or presyncope, think pulmonary embolism, pulmonary hypertension, and cardiomyopathy/right-heart failure before attributing it to normal pregnancy or URI.
If you want, I can also lay this out as:
1. an ED/hospital initial order set, or
2. a ranked problem representation with illness scripts.
User: **On examination, she is febrile (38°C), tachycardic (122 bpm), tachypnea (22/min), and has an oxygen saturation of 94% on room air.
Key Physical Findings:
Neck: Elevated JVP with a prominent v wave.
Cardiac: Split S2, a holosystolic murmur at the right sternal border, and a left parasternal heave.
Lungs: Scattered crackles without wheezing.
Skin: Reticular hyperpigmentation and trace pitting edema in lower limbs.
Initial Labs:
CBC: WBC 13,700 (predominantly neutrophils), Hb 11.2, Platelets 203,000.
Respiratory Pathogen Panel: Positive for Respiratory Syncytial Virus (RSV).
Chest X-ray: Initially interpreted as "Normal."**
Hello, Chief Resident here.
The clinical picture has shifted dramatically with these physical findings. We are no longer looking at a simple respiratory infection; we are witnessing acute-on-chronic right heart failure.
The presence of a left parasternal heave and prominent v waves indicates that the right ventricle is under significant pressure or volume overload. In a 26-week pregnant patient with UCTD, the most "can't miss" and likely underlying pathology is Pulmonary Hypertension, which carries a maternal mortality rate of 25-50%. The RSV infection has likely precipitated a "PAH crisis."
Warning: Avoid aggressive IV fluid boluses for her tachycardia; if this is RV failure, fluid overloading will worsen the septal shift and further decrease left ventricular cardiac output, leading to arrest.
Hello Attending Consultant here.
Critique of the proposed plan:
Refine to a single-page order set focused on stabilization, echo within 1 hour, and PE rule-out within 2 hours.
Hello, Expert Clinician here.
Previously unrecognized severe pulmonary hypertension with right ventricular failure, likely CTD-associated pulmonary arterial hypertension, now decompensated by pregnancy and RSV infection; acute PE remains the most important competing/overlapping diagnosis to urgently exclude.
This has become much more specific because the exam is now classic for chronic right-sided pressure overload with functional tricuspid regurgitation:
- Elevated JVP with prominent v wave → suggests TR/right-sided volume overload
- Left parasternal heave → RV pressure overload/enlargement
- Split/loud S2 → concerning for pulmonary hypertension
- Holosystolic murmur at right sternal border → likely tricuspid regurgitation
- Trace edema + crackles → evolving right-heart failure / mixed congestion
The normal hemoglobin removes severe anemia as the main driver.
The RSV positivity may be a trigger, but does not explain the full hemodynamic picture.
Why it fits best
- Connective tissue disease is a major cause of PAH
- Pregnancy at 26 weeks increases circulating volume and cardiac output, which can unmask/decompensate PAH
- Exam is highly supportive: parasternal heave, loud/split S2, JVP/v wave, TR murmur
- Exertional presyncope is a hallmark symptom of fixed pulmonary vascular obstruction / inability to augment output
- CXR can be “normal” early or be misread
Why caution remains
- Need echo confirmation and definition of severity
- Must still exclude PE because it can mimic or coexist
Why it still strongly fits
- Pregnancy = high VTE risk
- Acute worsening, tachycardia, borderline hypoxemia, chest tightness, presyncope
- Can produce RV strain, TR, elevated JVP
- Chest X-ray being “normal” does not lower PE concern much
Why it is slightly less unifying than PAH
- The exam suggests more than purely acute disease; parasternal heave and clear TR physiology raise concern for pre-existing pulmonary vascular disease
- Still, acute PE superimposed on chronic PAH is very plausible and dangerous
Why it fits
- Viral symptoms + RSV
- Tachycardia, dyspnea, crackles, presyncope
- Can present with arrhythmia and heart failure
Why it fits less well
- The exam pattern is more pulmonary vascular/right-sided pressure overload than primary LV failure
- Myocarditis usually gives a less specific right-heart exam unless secondary pulmonary hypertension develops
Why it fits partly
- Fever, neutrophilic leukocytosis, cough, RSV+
- Infection can precipitate decompensation of underlying cardiopulmonary disease
Why it does not fully fit
- RSV alone does not explain prominent v waves, parasternal heave, split S2, exertional presyncope
- “Scattered crackles” without significant infiltrates or wheeze is not enough
Why it fits
- UCTD with hypocomplementemia and prior cytopenias
- CTD can cause pneumonitis, serositis, myocarditis, or worsen pulmonary vascular disease
Why it is not the leading immediate diagnosis
- Current bedside physiology points more specifically toward pulmonary vascular/RV pathology
- The urgent task is defining the hemodynamic lesion
The key danger here is anchoring on RSV and missing a lethal maternal diagnosis.
In other words, the physical exam has now outranked the chest X-ray.
The exam converts this from nonspecific dyspnea in pregnancy into a syndrome of right-heart failure/right-heart strain.
That is the pivot.
The combination of:
- JVP elevation with v waves
- left parasternal heave
- split S2
- TR-type murmur
- exertional presyncope
is the bedside signature of pulmonary hypertension/RV failure until proven otherwise.
This is the single most important next test because it will rapidly determine whether she has:
- severe RV dilation/dysfunction
- elevated estimated pulmonary pressures
- significant tricuspid regurgitation
- septal flattening/D-sign
- LV dysfunction/myocarditis pattern
- pericardial effusion
This will also help risk-stratify whether she is in impending RV collapse.
Because PE remains a cannot-miss diagnosis, she also needs definitive pulmonary vascular imaging promptly:
- V/Q scan is reasonable if CXR truly normal and she is stable enough
- CTPA if faster, if CXR not truly normal, or if alternate thoracic pathology needs evaluation
In a deteriorating patient, speed and diagnostic certainty matter more than theoretical sequencing.
Immediate actions:
- Oxygen to maintain maternal saturation ideally >95%
- Continuous telemetry
- Maternal-fetal medicine + cardiology + pulmonary hypertension/ICU team
- Avoid large IV fluid boluses
- RV failure worsens with overfilling
- Consider careful diuresis only if congestion is evident and blood pressure tolerates it, ideally after echo guidance
- If PE suspicion remains high and bleeding risk acceptable, consider therapeutic anticoagulation while definitive imaging is pursued
- Avoid anything that increases pulmonary vascular resistance:
- hypoxemia
- acidosis
- pain/agitation
- excessive positive pressure if possible
If severe PAH/RV failure is confirmed, this may require specialized pulmonary vasodilator support.
This pregnant patient with UCTD has bedside findings most consistent with significant pulmonary hypertension and right-sided heart failure, likely pre-existing CTD-associated PAH now decompensated by pregnancy and RSV, with superimposed pulmonary embolism still needing urgent exclusion.
In dyspneic pregnancy, a “viral diagnosis” should never end the evaluation when the exam shows right-heart strain.
A parasternal heave + loud/split S2 + JVP elevation with TR murmur + exertional presyncope is a high-yield bedside pattern for pulmonary hypertension/RV failure.
If you want, I can next provide:
1. a prioritized ICU/ED order set, or
2. a maternal mortality–focused management plan for pulmonary hypertension in pregnancy.
User: **An Electrocardiogram (ECG) is performed, showing sinus tachycardia with right-axis deviation and T-wave inversions in leads II, III, aVF, and V3 to V5.
A "re-read" of the initial Chest X-ray reveals:
Prominence of the right descending pulmonary artery.
A large left central pulmonary artery with obliteration of the aortopulmonary window.
Diminished retrosternal clear space on the lateral view.
Biomarkers: BNP is elevated at 362 pg/mL (Normal < 100). Troponin is normal.
Imaging:
CTPA: No pulmonary embolism. Confirms tree-in-bud nodularity (RSV) and right ventricular enlargement.
Echocardiogram: Small, hyperdynamic LV (EF 75%). Marked RV dilatation with severely reduced systolic function and septal flattening ("D-shaped" LV). Severe tricuspid regurgitation with an estimated RVSP of 74 mmHg.**
Resident:
Hello, Chief Resident here.
The diagnosis is now definitive: Severe Pulmonary Arterial Hypertension (PAH) with Acute Right Ventricular (RV) Failure, likely chronic CTD-associated PAH that has reached a tipping point due to the hemodynamic demands of the second trimester and an acute RSV infection.
The patient is in a Pulmonary Hypertension Crisis. The "D-shaped" LV is a critical finding; it explains her exertional presyncope. When she exerts herself, RV pressure rises further, pushing the septum into the LV, which reduces LV filling (preload) and leads to a sudden drop in systemic cardiac output. This is a life-threatening emergency in pregnancy, with maternal mortality historically cited between 25% and 50%.
Transfer to a specialized Pulmonary Hypertension center if not already there. Discuss the transition to long-term PAH therapies (e.g., Sildenafil, which is generally considered safe in pregnancy) once stabilized. The RSV should be treated supportively. Strict avoidance of future pregnancies must be discussed once the crisis is resolved, given the extreme risk.
Hello Attending Consultant here.
Critique of the proposed plan:
Refine to immediate stabilization bundle: echo-directed therapy, selective pulmonary vasodilation, and multidisciplinary huddle within 1 hour.
Hello, Expert Clinician here.
Severe pulmonary arterial hypertension with decompensated right ventricular failure, most likely connective tissue disease–associated PAH, unmasked/worsened by pregnancy and precipitated by RSV respiratory infection.
This is now the clear diagnosis.
The data are internally coherent for advanced pulmonary vascular disease with RV failure:
- ECG: right-axis deviation + anterior/inferior T-wave inversions = RV strain
- CXR re-read: enlarged central pulmonary arteries + reduced retrosternal clear space = pulmonary artery enlargement + RV enlargement
- CTPA: no PE, but RV enlargement
- Echo:
- marked RV dilation
- severely reduced RV systolic function
- septal flattening/D-shaped LV = RV pressure overload
- severe tricuspid regurgitation
- RVSP ~74 mmHg = severe pulmonary hypertension
- small hyperdynamic LV = underfilled LV from interventricular septal shift / impaired preload
- BNP elevated, troponin normal = myocardial wall stress, especially RV strain, without clear ischemic injury
This explains:
- progressive exertional dyspnea
- palpitations
- exertional presyncope
- elevated JVP/v wave
- parasternal heave
- split S2
- TR murmur
- edema/crackles
Her UCTD background makes this the leading cause:
- autoimmune connective tissue disease is a classic substrate for Group 1 PAH
- pregnancy increases blood volume and cardiac output, often exposing previously compensated pulmonary vascular disease
- RSV likely precipitated decompensation, rather than caused the underlying hemodynamic disease
Fits because
- classic exam, ECG, CXR, echo, BNP pattern
- autoimmune disease is a strong etiologic clue
- PE has been excluded on CTPA
Does not fit less well than alternatives
- It explains both the chronicity and the acute tipping point
Still worth considering as part of the etiologic workup, though not the immediate management pivot.
Possibilities:
- chronic thromboembolic disease
- interstitial lung disease/hypoxic lung disease
- left-sided cardiac disease less likely here
- portal hypertension/congenital disease depending on history
Why less likely right now
- Current data strongly favor precapillary pulmonary vascular disease with RV failure
- CTPA excluded acute PE, but not all chronic thromboembolic disease
Why it was plausible
- viral trigger, pregnancy, dyspnea, palpitations
Why it is now less likely
- LV is hyperdynamic and small, not failing
- echo phenotype is RV pressure overload, not primary global cardiomyopathy
- troponin is normal
Why it contributes
- RSV likely increased hypoxic pulmonary vasoconstriction and cardiopulmonary stress
- CT shows tree-in-bud nodularity consistent with viral bronchiolar process
Why it is not the primary diagnosis
- RSV does not explain severe pulmonary artery enlargement and this degree of RV remodeling/decompensation by itself
- It is best viewed as a trigger
The key pivot is the echo: small hyperdynamic LV + massively abnormal RV + D-shaped septum + severe TR + RVSP 74.
That pattern is the bedside-and-imaging signature of severe precapillary pulmonary hypertension with RV failure, not PE, not anemia, and not primary LV disease.
This is the most important move.
Oxygen
- keep saturation high, ideally >95% in pregnancy
- avoid hypoxemia because it worsens pulmonary vasoconstriction
Avoid RV precipitants
- no large fluid boluses
- avoid hypovolemia too
- avoid acidosis, pain, agitation, hypothermia
- avoid unnecessary positive-pressure ventilation if possible, as it can worsen RV preload and afterload dynamics
Selective pulmonary vasodilation
- in acute decompensation, consider inhaled nitric oxide or inhaled epoprostenol/prostacyclin
- these can reduce pulmonary vascular resistance while minimizing systemic hypotension
Hemodynamic support if needed
- if hypotensive or showing low output, norepinephrine is generally preferred to maintain coronary perfusion and systemic pressure
- arterial line is appropriate in a deteriorating patient
Careful preload management
- if clinically congested, cautious diuresis may help
- but this should be done carefully because severe RV failure is preload sensitive
Multidisciplinary team now
- maternal-fetal medicine
- pulmonary hypertension specialist
- cardiac ICU/critical care
- anesthesia
- cardiology
- neonatology if maternal deterioration threatens delivery timing
Although the syndrome is now clear, formal etiologic classification still matters.
Right heart catheterization at an expert center, if the team believes it can be done safely and will alter management.
Why:
- confirms precapillary PH physiology
- measures RA pressure, PAP, PCWP, cardiac output, PVR
- guides vasodilator and inotrope strategy
- helps distinguish severity and prognosis
In a crashing patient, therapy may begin before definitive catheter-based characterization.
Once stabilized:
- autoimmune assessment/activity
- V/Q scan later if concern for chronic thromboembolic PH persists despite negative CTPA
- pulmonary function testing and diffusion capacity
- evaluation for ILD, sleep-disordered breathing, liver disease, congenital shunt if relevant
Pregnancy with severe PAH carries very high maternal risk, especially:
- late pregnancy
- labor/delivery
- early postpartum fluid shifts
So the immediate priority is maternal stabilization, not reflex delivery. Delivery can be catastrophic if undertaken before hemodynamics are optimized.
A small hyperdynamic LV in a dyspneic patient can be a clue to severe RV failure, not circulatory wellness.
When the RV is pressure overloaded, the septum bows into the LV, reducing LV filling; the LV may look “strong” but is actually underfilled, and the patient is at risk for low-output collapse.
If you want, I can next provide a stepwise ICU management algorithm for decompensated PAH in pregnancy.
User: **Right Heart Catheterization is performed:
Mean Pulmonary Artery Pressure (mPAP): 57 mmHg (Severe).
Pulmonary Capillary Wedge Pressure (PCWP): 5 mmHg (Normal).
Cardiac Output: 2.7 L/min (Severely low for pregnancy, where 6.0 is expected).
Pulmonary Vascular Resistance (PVR): 19.2 Wood Units (Normal < 2).
Nitric Oxide Challenge: No response (Vasoreactivity negative).
A V/Q scan is performed and is normal, ruling out Chronic Thromboembolic Pulmonary Hypertension (CTEPH).**
Resident:
Hello, Chief Resident here.
The Right Heart Catheterization (RHC) and V/Q scan have provided the definitive hemodynamic and etiologic classification. We are dealing with Group 1 Pulmonary Arterial Hypertension (PAH), specifically associated with Undifferentiated Connective Tissue Disease (UCTD), in a state of acute-on-chronic right ventricular failure.
The patient is in a low-output state due to RV-LV mismatch. The high PVR prevents the RV from pumping blood through the lungs to the left heart. The resulting low LV preload (demonstrated by the "small, hyperdynamic LV" on echo and low CO on RHC) leads to systemic hypotension and syncope during exertion. At 26 weeks, she is in the most dangerous period of pregnancy for this condition.
This is a classic but tragic presentation of CTD-associated PAH unmasked by pregnancy. The patient’s UCTD (likely a precursor to Systemic Sclerosis or SLE) caused silent pulmonary vascular remodeling that became symptomatic only when pregnancy and RSV increased the hemodynamic burden beyond the RV's compensatory capacity. The focus is now on aggressive pulmonary vasodilation and preventing maternal cardiovascular collapse during the upcoming delivery.
Hello Attending Consultant here.
Critique of the proposed plan:
Refine to a 24-hour stabilization protocol focused on prostacyclin up-titration, invasive hemodynamics, and MFM/PH team huddle before any obstetric intervention.
Hello, Expert Clinician here.
High-risk Group 1 pulmonary arterial hypertension, most likely connective tissue disease–associated PAH, with severe decompensated right ventricular failure in pregnancy.
The hemodynamics are definitive:
- mPAP 57 mmHg → severe pulmonary hypertension
- PCWP 5 mmHg → precapillary process, not left-sided heart failure
- PVR 19.2 WU → profound pulmonary vascular disease
- CO 2.7 L/min → critically low output, especially abnormal in pregnancy
- No vasoreactivity to nitric oxide → not a calcium-channel-blocker candidate
- Normal V/Q scan → argues strongly against CTEPH
So this is no longer just “pulmonary hypertension”; it is severe precapillary PAH with low-output RV failure, and the most plausible etiology is her underlying connective tissue disease.
This integrates the whole case:
- Subacute exertional dyspnea progressing to exertional presyncope
- Exam showing TR, RV heave, elevated JVP, loud/split S2
- ECG with RV strain
- Imaging showing RV enlargement and enlarged pulmonary arteries
- Echo showing severe RV dysfunction with septal flattening
- RHC confirming severe precapillary pulmonary vascular disease
- Pregnancy and RSV acting as decompensating stressors
This is classic physiology of:
fixed severe pulmonary vascular resistance → RV failure → underfilled LV → low cardiac output → presyncope/exertional collapse risk
Fits
- Established autoimmune disease
- Clear precapillary PH on catheterization
- CTEPH excluded
- No evidence of left heart disease
- Hemodynamics severe and characteristic
Doesn’t not fit
- This is the diagnosis unless a rare alternative CTD-adjacent cause emerges
Why it was considered
- RSV positive
- Tree-in-bud nodularity
Why it does not explain the syndrome
- RSV/bronchiolitis does not usually produce PVR 19.2 WU with this degree of chronic RV remodeling
- Infection is a trigger, not the primary disease
Why it mattered
- Can present with severe precapillary PH and RV failure
Why it is now effectively excluded
- Normal V/Q scan
- No acute PE on CTPA
Why it was in the early differential
- Dyspnea, crackles, BNP elevation
Why it is not the answer
- PCWP normal
- LV is small and hyperdynamic, not failing
- Hemodynamics are precapillary, not postcapillary
The decisive pivot is the right heart catheterization: severe precapillary pulmonary hypertension with markedly elevated PVR and very low cardiac output.
That moves the case from suspected PH to a hemodynamically proven, high-risk PAH crisis phenotype.
This is the most important move.
She is high risk by every major feature:
- severe symptoms
- RV failure
- elevated BNP
- low cardiac output
- severe PVR elevation
- pregnancy
For this phenotype, parenteral prostacyclin, especially IV epoprostenol, is the cornerstone therapy.
Why:
- strongest evidence and most established rescue/bridge therapy in severe PAH
- appropriate for high-risk, low-output, RV failure disease
- nonreactive vasodilator testing means do not use calcium channel blockers
Can also consider adjuncts later:
- PDE-5 inhibitor such as sildenafil
- inhaled pulmonary vasodilators in the acute phase
But the anchor therapy is parenteral prostacyclin.
Goals:
- maintain systemic pressure to preserve RV coronary perfusion
- avoid precipitants of rising PVR:
- hypoxemia
- acidosis
- pain/anxiety
- hypercapnia
- excessive PEEP if intubated
This is a narrow hemodynamic window:
- too much volume worsens RV dilation and septal shift
- too little volume drops LV filling further
This is crucial.
At 26 weeks, immediate delivery is not the reflex move unless there is refractory maternal collapse or an obstetric indication that cannot wait.
The highest-risk period for PAH patients is often delivery and early postpartum, because of sudden preload/autotransfusion shifts.
So:
- stabilize first
- coordinated planning by MFM + PH team + cardiac anesthesia + ICU + neonatology
- delivery only in a controlled, expert setting once a strategy exists
This is essentially:
- WHO Group 1 PAH
- likely CTD-associated
- with high-risk features / near WHO functional class IV physiology
Her cardiac output is especially ominous in pregnancy because normal gestation should increase output substantially; instead she is profoundly low output.
This is a maternal high-mortality condition, especially:
- second/third trimester
- delivery
- postpartum
The low CO and severe RV dysfunction are the most worrisome prognostic elements.
In pulmonary hypertension, the most dangerous number is often not the pulmonary pressure alone—it is the cardiac output.
A patient with very high PAP but preserved RV output may compensate; once the RV fails and cardiac output falls, risk of syncope, shock, and death rises sharply.
If you want, I can next give:
1. a 24-hour ICU stabilization protocol, or
2. a board-style final diagnosis + management summary.